BackgroundSmoking is a key driver of health inequalities and a leading cause of cancer incidence in the UK. Stop Smoking Services (SSS) offer a combination of behavioural and pharmacological support. Individuals who use SSS are three times more likely to successfully quit than those who try to quit unaided, but uptake of services is low, particularly amongst people from low socioeconomic backgrounds. The aim of this qualitative study was to understand the barriers and facilitators to accessing SSS in this population. MethodsQualitative interviews with SSS providers (pharmacists, SSS leads, and advisors; n=22) and potential or current service users from low socioeconomic backgrounds (n=115) across the UK. Interviews were coded thematically using NVivo and analysed using the COM-B model which cites Capability (C), Opportunity (O), and Motivation (M) as factors for changing behaviour (B). Informed consent was obtained verbally prior to interviews. FindingsFacilitators to accessing SSS included proximity of services, flexibility of service delivery, and free NRT provision. Barriers included waiting lists, staffing shortages, lack of service visibility and advertisement, and perceived stigma and lifestyle factors. The use of smart phones/apps in service provision was identified as both a barrier and facilitator. Recommendations for service enhancement included improved visibility and awareness of SSS (Capability), enhanced community links to embed services or support referral pathways (Opportunity) and person-centred approaches to SSS delivery (Motivation). InterpretationOur findings provide evidence on practical solutions for adapting SSS delivery, with potential to increase equitable uptake and improve outcomes. Removing structural barriers through tailored support and targeted promotion of local SSS is essential to maximise service uptake. The use of community outreach services/agencies was identified as an important way of maximising targeted work to improve access to SSS in low socioeconomic settings. FundingThis study was funded by Cancer Research UK.
Read full abstract